Endogenous thrombopoietin serum levels during multicycle chemotherapy

British Journal of Haematology

Volumn 105, Issue 3, 1999, Pages 832-838

  Engel, Christoph ^a   Loeffler, Markus ^a   Franke, Horst ^a   Schmitz, Stephan ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Chemotherapy; Human; Regulation; Thrombocytopenia; Thrombopoietin

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; PREDNISONE; PROCARBAZINE; THROMBOPOIETIN; VINCRISTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; FEMALE; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PLATELET COUNT; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 0033066658     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01459.x     Document Type: Article

References (29)

1. Basser, R.L., Rasko, J.E., Clarke, K., Cebon, J., Green, M.D., Gripp, A.P., Zalcberg, J., Cohen, B., O'Byrne, J., Menchaca, D.M., Fox, R.M. & Begley, C.G. (1997) Randomized, blinded. placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood, 89, 3118-3128.
2. Broudy, V.C. & Kaushansky, K. (1995) Thrombopoietin, the c-mpl ligand, is a major regulator of platelet production. Journal of Leukocyte Biology, 57, 719-725.
3. Chang, M., Suen, Y., Meng, G., Buzby, J.S., Bussel, J., Shen, V., van de Ven, C. & Cairo, M.S. (1996) Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production. Blood, 88, 3354-3362.
4. Diehl, V., Franklin, J., Hasenclever, D., Tescb, H., Pfreundschuh, M., Lathan, B., Paulus, U., Sieber, M., Rueffer, J.U., Sextro, M., Engert. A., Wolf, J., Hermann, R., Holmer, J., Stappert-Jahn, U., Winnerlein-Trump, E., Wulf, G., Krause, S., Glunz, A., von Kalle, K., Bischoff, H., Haedicke, C., Duchmke, E., Georgii, A. & Loeffler, M. (1998a) BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group. Journal of Clinical Oncology, 16, 3810-3821.
5. Diehl, V., Franklin, J., Sieber, M., Hasenclever, D., Paulus, U., Tesch, H., Pfreundschuh, M., Rueffer, U., Hermann, R., Longin, C., Haenel, M., Wulf, G., Aulitzky, W., Georgii, A., Duehmke, E. & Loefller, M. (1998b) Increased efficacy through moderate dose escalation of chemotherapy: interim report from the HD9 randomised trial for advanced Hodgkin's disease. Blood, 92, abstract 2002.
6. Emmons, R.V., Reid, D.M., Cohen, R.L., Meng, G., Young, N.S., Dunbar, C.E. & Shulman, N.R. (1996) Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood, 87, 4068-4071.
7. Engel, C., Tesch, H., Franke, H., Loeffler, M., Diehl, V. & Schmitz, S. (1998) Acute hematotoxicity of the BEACOPP chemotherapy regiment: experience from the HD9 study of the German Hodgkin's Lymphoma Study Group (GHSG). Leukemia and Lymphoma, 29, (Suppl. 1), P-94.
8. Fanucchi, M., Glaspy, J., Crawford, J., Garst, J., Figlin, R., Sheridan, W., Menchaca, D., Tomita, D., Ozer, H. & Harker, L. (1997) Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. New England Journal of Medicine, 336, 404-409.
9. Fielder, P.J., Gurney, A.L., Stefanich, E., Marian, M., Moore, M.W., Carver-Moore, K. & de Sauvage, F.J. (1996) Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood, 87, 2154-2161.
10. Fielder, P.J., Hass, P., Nagel, M., Stefanich, E., Widmer, R., Bennet, G.L., Keller, G.A., de Sauvage, F.J. & Eaton, D. (1997) Human platelets as a model for the binding and degradation of thrombopoietin. Blood, 89, 2782-2788.
11. Hamaguchi, M., Yamada, H., Morishima, Y., Morishita, Y., Kato, Y., Sao, H., Kanic, T., Murata, M., Taji, H., Nakayama, Y., Minami, S., Saito, H. & Kodera, Y. (1996) Serum thrombopoietin level after allogeneic bone marrow transplantation: possible correlations with platelet recovery, acute graft-versus-host disease and hepatic veno-occlusive disease. Nagoya Bone Marrow Transplantation Group. International Journal of Hematology, 64, 241 -248.
12. Hou, M., Andersson, P.O., Stockelberg, D., Mellqvist, U.H., Ridell, B. & Wadenvik, H. (1998) Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes. British Journal of Haematology, 101, 420-424.
13. Ichikawa, N., Ishida, F., Shimodaira, S., Tahara, T., Kato, T. & Kitano, K. (1996) Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura. Thrombosis and Hemostasis, 76, 156-160.
14. Ishida, A., Miyakawa, Y., Tanosaki, R., Wakui, M., Ueno, H., Watanabe, R., Awaya, N., Tahara, T., Kato, T., Miyazaki, H., Oda, A., Kizaki, M., Okamoto, S. & Ikeda, Y. (1996) Circulating endogenous thrombopoietin, interleukin-3, interleukin-6 and interleukin-11 levels in patients undergoing allogeneic bone marrow transplantation. International Journal of Hematology, 65, 61-69.
15. Kaushansky, K. (1998) Thrombopoietin. New England Journal of Medicine, 339, 746-754.
16. Kloess, M., Wunderlich, A., Pfreundschuh, M. & Loeffler, M. (1998) Prognostic factors for hematotoxicity of CHOP-like multicycle chemotherapy in aggressive NHL. Blood, 92, Abstract 362.
17. Kuter, D.J. & Rosenberg, R.D. (1995) The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood, 85, 2720-2730.
18. Lok, S. & Foster, D.C. (1994) The structure, biology and potential therapeutic applications of recombinant thrombopoietin. Stem Cells, 12, 586-598.
19. Meng, Y.G., Martin, T.G., Peterson, M.L., Shuman, M.A., Cohen, R.L. & Wong, W.L. (1996) Circulating thrombopoietin concentrations in thrombocytopenic patients, including cancer patients following chemotherapy, with or without peripheral blood progenitor cell transplantation. British Journal of Haematology, 95, 535-541.
20. Mukai, H.Y., Kojima, H., Todokoro, K., Tahara, T., Kato, T., Hasegawa, Y., Kobayashi, T., Ninomiya, H., Nagasawa, T. & Abe, T. (1996) Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura. Thrombosis and Hemostasis, 76, 675-678.
21. Nichol, J.L., Hokom, M.M., Hornkohl, A., Sheridan, W.P., Ohashi, H., Kato, T., Li, Y.S., Bartley, T.D., Choi, E. & Bosenberger, J. (1995) Megakaryocyte growth and development factor: analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. Journal of Clinical Investigation, 95, 2973-2978.
22. Oh, H., Nakamura, H., Yokota, A., Asai, T. & Saito, Y. (1996) Serum thrombopoietin levels in cyclic thrombocytopenia. Blood, 87, 4918.
23. O'Malley, C.J., Rasko, J.E., Basser, R.L., McGrath, K.M., Cebon, J., Grigg, A.P., Hopkins, W., Cohen, B., O'Byrne, J., Green, M.D., Fox, R.M., Berndt, M.C. & Begley, C.G. (1996) Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood, 88, 3288-3298.
24. Shimazaki, C., Inaba, T., Uchiyama, H., Sumikuma, T., Kikuta, T., Hirai, H., Sudo, Y., Yamagata, N., Asbihara, E., Goto, H., Murakami, S., Haruyama, H., Fujita, N. & Nakagawa, M. (1997) Serum thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation, 19, 771-775.
25. Stoffel, R., Wiestner, A. & Skoda, R.C. (1996) Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood, 87, 567-573.
26. Tesch, H., Diehl, V., Lathan, B., Hasenclever, D., Sieber, M., Rueffer, U., Engert, A., Franklin, J., Pfreundschuh, M., Schalk, K.P., Schwieder, G., Wulf, G., Dolken, G., Worst, P., Koch, P., Schmitz, N., Bruntsch, U., Tirier, C., Mueller, U. & Loeffler, M. (1998) Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine. procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group. Blood, 92, 4560-4567.
27. Truemper, L., Renner, C., Kloess, M., Hasenclever, D., Schnabel, K., Feller, A.C., Loeffler, M. & Pfreundschuh, M. (1996) Therapy of high-grade Non-Hodgkin's lymphomas with CHOEP (CHOP + etoposide) in 14-day intervals: a phase III multicenter trial of the German NHL-Consensus Trial Group. Annals of Oncology, 7, (Suppl. 3), abstract 201.
28. Truemper, L., Schmits, R., Kloess, M., Renner, C., Hasenclever, D., Loeffler, M. & Pfreundschuh, M. (1998) Dose escalation in high-grade non-Hodgkin's lymphoma: the role of dose intensity and dose density. Annals of Hematology, 77, (Suppl. 1), abstract 72.
29. Vadhan-Raj, S., Murray, L.J., Bueso-Ramos, C., Patel, S., Reddy, S.P., Hoots, W.K., Johnston, T., Papadopolous, N.E., Hittelman, W.N., Johnston, D.A., Yang, T.A., Paton, V.E., Cohen, R.L., Hellmann, S.D., Benjamin, R.S. & Broxmeyer, H.E. (1997) Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Annals of Internal Medicine, 126, 673-681.